• News
  • SAN DIEGO
  • BioTech

DexCom cited as bellwether

CNBC stock commentator Jim Cramer on Friday cited San Diego’s DexCom Inc. (Nasdaq: DXCM) as a bellwether for the stock market, which should go into a turnaround on Wall Street within the next year.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

Dexcom Inc.

Company Website

5555 Oberlin Drive
San Diego, CA 92121

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
DXCM
50.37
  -0.48  
- 0.94%
738,976,000
54.50
28.09

Insider Trade Data

Date Insider Shares Type Value
11/17/2014 Gregg, Terrance H 125,000 Sell $6,632,186
11/17/2014 Gregg, Terrance H 115,000 Exchange $976,750
11/12/2014 Gregg, Terrance H 80,000 Sell $4,268,815
11/12/2014 Gregg, Terrance H 80,000 Exchange $716,000
11/12/2014 Lister, John 3,078 Sell $162,560

Dexcom Inc. Executive(s):

Terrance Gregg

  • Chief Executive Officer, Director

Kevin Sayer

  • Director, President

Patrick Murphy

  • Assist. General Counsel

Similar Companies

NAICS - -
Subscribe Today!